RIZZOTTO, Lara
 Distribuzione geografica
Continente #
NA - Nord America 4.084
AS - Asia 2.070
EU - Europa 1.143
SA - Sud America 248
Continente sconosciuto - Info sul continente non disponibili 46
AF - Africa 41
OC - Oceania 5
Totale 7.637
Nazione #
US - Stati Uniti d'America 3.987
SG - Singapore 794
CN - Cina 522
DE - Germania 267
VN - Vietnam 250
BR - Brasile 195
IT - Italia 179
UA - Ucraina 153
HK - Hong Kong 136
GB - Regno Unito 127
TR - Turchia 121
FR - Francia 78
BD - Bangladesh 77
FI - Finlandia 77
CA - Canada 60
SE - Svezia 60
RU - Federazione Russa 59
JP - Giappone 48
IN - India 42
MX - Messico 30
ES - Italia 25
BE - Belgio 21
PL - Polonia 20
CZ - Repubblica Ceca 19
ID - Indonesia 19
ZA - Sudafrica 16
NL - Olanda 14
AR - Argentina 13
LT - Lituania 13
PK - Pakistan 12
CO - Colombia 10
CL - Cile 9
VE - Venezuela 9
IQ - Iraq 8
MA - Marocco 8
RO - Romania 7
MY - Malesia 6
AT - Austria 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
BO - Bolivia 4
EG - Egitto 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
EC - Ecuador 3
JO - Giordania 3
PH - Filippine 3
TN - Tunisia 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
DZ - Algeria 2
IE - Irlanda 2
IL - Israele 2
KE - Kenya 2
KR - Corea 2
LY - Libia 2
MT - Malta 2
NG - Nigeria 2
PE - Perù 2
PY - Paraguay 2
RS - Serbia 2
TW - Taiwan 2
AZ - Azerbaigian 1
BB - Barbados 1
CH - Svizzera 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LV - Lettonia 1
MD - Moldavia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TO - Tonga 1
TZ - Tanzania 1
UY - Uruguay 1
VI - Stati Uniti Isole Vergini 1
Totale 7.592
Città #
Singapore 519
Ashburn 475
Woodbridge 359
San Jose 297
Chandler 254
Fairfield 252
Beijing 213
Santa Clara 187
Jacksonville 171
Houston 152
Ann Arbor 150
Hong Kong 132
Seattle 112
Wilmington 101
Cambridge 97
Dallas 97
New York 95
Ho Chi Minh City 82
Council Bluffs 78
Los Angeles 72
Izmir 64
Munich 61
Hanoi 58
Ferrara 49
Tokyo 45
Nanjing 42
Milan 39
Princeton 38
Shanghai 37
Lauterbourg 34
Boardman 33
São Paulo 28
Helsinki 23
San Diego 23
Bremen 22
London 22
Orem 22
Buffalo 21
Brussels 20
Mexico City 20
Turku 19
Shenyang 18
Warsaw 18
Dearborn 17
Denver 17
Montreal 17
Frankfurt am Main 16
Nanchang 16
Toronto 16
Addison 15
Brno 15
Brooklyn 14
The Dalles 14
Tianjin 14
Changsha 13
Johannesburg 13
San Francisco 13
Stockholm 13
Da Nang 12
Chennai 11
Manchester 11
Phoenix 11
Amsterdam 10
Guangzhou 10
Chicago 9
Jiaxing 9
Jinan 9
Moscow 9
Mumbai 9
Zhengzhou 9
Atlanta 8
Bologna 8
Falkenstein 8
Haiphong 8
Jakarta 8
Poplar 8
Rio de Janeiro 8
Auburn Hills 7
Biên Hòa 7
Columbus 7
Dortmund 7
Hefei 7
Mountain View 7
Paris 7
Reynoldsburg 7
Norwalk 6
Orange 6
Washington 6
Bexley 5
Boston 5
Bến Tre 5
Caracas 5
Falls Church 5
Guarulhos 5
Ninh Bình 5
Secaucus 5
Augusta 4
Calgary 4
Can Tho 4
Detroit 4
Totale 5.179
Nome #
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 297
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 274
Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 262
U1-snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 256
U1snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 254
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 254
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 251
Chromosome Aberrations by Conventional Karyotyping in Chronic Lymphocytic Leukemia Carrying No Aberration by Fluorescence in Situ Hybridization: Correlation with Prognostic Parameters and Clinical Features 250
Employment of Oligodeoxynucleotide plus Interleukin-2 Improves Cytogenetic Analysis in SplenicMarginal Zone Lymphoma 232
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia 229
A Prospective, Multi Center Phase II Study Evaluating Predictive Factors for Lenalidomide Treatment in Relapse or Refractory Chronic Lymphocytic Leukemia Patients (LE.P.RE.): Preliminary Results about the First 20 Enrolled Patients 227
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: Correlations with clinicobiologic parameters 226
Aberrant splicing reverts a potentially lethal coagulation deficiency caused by a +1g/t splicing mutation 220
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 210
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 209
LATE APPEARANCE of 14q32/IGH TRANSLOCATION In CHRONIC LYMPHOCYTIC LEUKEMIA. 207
The complete impairment of factor VII gene expression by the IVS6+1g/t mutation is compatible with a severe but not lethal bleeding disorder 205
Natural and engineered carboxy-terminal variants: decreased secretion and gain-of-function result in asymptomatic coagulation factor VII deficiency 200
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 196
Clonal evolution in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 194
Multiparametric flow cytometric characterization of circulating stem cell subsets in patients with myocardial infarction: correlation with clinical and biological data 191
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide 184
Association of the homozygous nonsense mutation R402X in coagulation factor VII with asymptomatic phenotype 181
The F7 p.Val22Ile missense mutation affects splicing and can be counteracted by a compensatory U1snRNA 177
Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays 174
Rescue of coagulation factor VII function by the U1+5A snRNA 172
Non-conventional therapeutic strategies for inherited disorders oh hemostasis 167
IN CHRONIC LYMPHOCYTIC LEUKEMIA THE AMOUNT OF PROLIFERATION CENTERS IN TISSUE-BIOPSIES CORRELATES WITH UNFAVORABLE CYTOGENETIC ABNORMALITIES 159
Non-conventional therapeutic strategies for inherited disorders of hemostasis 155
Intracellular evaluation of ER targeting elucidates a mild form of inherited coagulation deficiency 155
Diagnostic workup for clinical and prognostic assessment of acute leukemia. 141
Rescue of coagulation factor VII mRNA processing and protein function by engineered U1+5A snRNA 138
“Compensatory” aberrant splicing supports residual expression levels in severe coagulation factor VII deficiency 134
The FVII R402X nonsense mutation, associated with an asymptomatic phenotype, is responsible for small amounts of circulating protein with improved coagulant activity 133
Extended lifespan of normal human B lymphocytes experimentally infected by SV40 or transfected by SV40 large T antigen expression vector 130
Erratum to: Circulating endothelial cells in patients with chronic lymphocytic leukemia: Clinical-prognostic and biologic significance (Cancer (2010) 116, (1926-37)) 115
Naturally occurring truncated proteins: decreased protein secretion and increased activity result in asymptomatic coagulation factor deficiency 112
null 94
Intracellular readthrough of nonsense mutations by aminoglycosides in coagulation factor VII 84
null 82
null 64
null 42
Totale 7.637
Categoria #
all - tutte 32.374
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.374


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022404 0 55 27 10 29 18 16 21 9 34 50 135
2022/2023524 49 52 8 80 96 68 28 44 66 2 22 9
2023/2024233 25 26 9 3 12 50 9 12 8 6 3 70
2024/2025986 14 24 73 45 137 107 9 22 162 91 142 160
2025/20263.080 333 113 242 380 468 223 394 164 243 284 150 86
2026/2027184 66 118 0 0 0 0 0 0 0 0 0 0
Totale 7.637